Targeted therapy in head and neck cancer: state of the art 2007 and review of clinical applications.
about
Inhibition of Rho-associated coiled-coil containing protein kinase enhances the activation of epidermal growth factor receptor in pancreatic cancer cells.Immunological treatment options for locoregionally advanced head and neck squamous cell carcinomaCetuximab in the treatment of head and neck cancer: preliminary results outside clinical trialsImmune biomarkers of anti-EGFR monoclonal antibody therapyPhase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part.Unique FISH patterns associated with cancer progression of oral dysplasia.Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patientsPhase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoMetronomic dosing of BH3 mimetic small molecule yields robust antiangiogenic and antitumor effectsOverview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma.Emerging molecular targeted therapies in the treatment of head and neck cancer.A review on the treatment of relapsed/metastatic head and neck cancer.Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck.Targeted therapy in head and neck cancer.Integrating molecular docking, DFT and CoMFA/CoMSIA approaches for a series of naphthoquinone fused cyclic α-aminophosphonates that act as novel topoisomerase II inhibitors.Cucurbitacin B inhibits growth, arrests the cell cycle, and potentiates antiproliferative efficacy of cisplatin in cutaneous squamous cell carcinoma cell lines.The role of EGFR-targeting strategies in the treatment of head and neck cancerEGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer.Retrospective analysis of chronomodulated chemotherapy versus conventional chemotherapy with paclitaxel, carboplatin, and 5-fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.Phase Ib trial of the Toll-like receptor 9 agonist IMO-2055 in combination with 5-fluorouracil, cisplatin, and cetuximab as first-line palliative treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck.Epidermal growth factor receptor mutations in patients with oral cavity cancer in a betel nut chewing-prevalent area.Biomarker-directed therapy of squamous carcinomas of the head and neck: targeting PI3K/PTEN/mTOR pathway.Advances and Prospects in Cancer Immunotherapy
P2860
Q33948775-66CD4C8E-EA50-41F3-A58C-3B84679F1DBAQ34181954-930491EF-02C5-44AB-9EAA-233EC0E825CFQ34417953-D3ADC956-62CF-4964-BEB0-886082CCEC07Q34723594-C973A166-CFF4-40EA-BF82-F000339E2FEBQ35034608-D77F4D75-0889-40D5-87FF-FC75820609B9Q35596552-0B035F18-1791-4950-9F9F-BDF1EBF4888CQ36286498-3CB21A17-1626-480B-914C-C8872D502A7CQ36947423-96592A72-E7F0-4593-8965-20C00F76C102Q37109324-A115020C-4CE3-4C0B-9CD4-DCDB91C9180CQ37414399-0FAD541B-B367-44E0-A32A-2B7A42EA9E72Q37515438-AD76DB01-B500-40AF-BBA5-0DB0EE9F5C2FQ37587235-AAD68324-6C14-4841-9F22-3C27610C95CCQ37952659-F26CE598-E51C-482F-8050-1697391FD965Q37988981-4F8444B1-5464-4355-8524-30A1B6DC8917Q39627560-C48A21FB-BA48-4A81-B36A-ECAD288CA1EFQ39674848-EC20C854-5476-4349-B877-1F319C80E520Q41869362-3676FF22-08A2-454A-BDA0-73A0ABE1F90CQ42520266-72D3A41C-D6BD-441F-9209-3E0CDCB1ADD6Q42931593-50C900FC-C45C-4B01-B111-2E8DA0E2E4BAQ45732639-BC0C172A-3C5A-4E37-AA07-B20F1D9399BAQ53270990-91070184-5E6B-4296-B439-6ADB05913BF7Q55395494-DB4F798A-E5E8-4CA2-A432-742E69F79E95Q59072375-89BB0029-C026-4D94-8E69-32674959FE22
P2860
Targeted therapy in head and neck cancer: state of the art 2007 and review of clinical applications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted therapy in head and n ...... view of clinical applications.
@en
Targeted therapy in head and n ...... view of clinical applications.
@nl
type
label
Targeted therapy in head and n ...... view of clinical applications.
@en
Targeted therapy in head and n ...... view of clinical applications.
@nl
prefLabel
Targeted therapy in head and n ...... view of clinical applications.
@en
Targeted therapy in head and n ...... view of clinical applications.
@nl
P2860
P356
P1433
P1476
Targeted therapy in head and n ...... view of clinical applications.
@en
P2093
Corey J Langer
P2860
P304
P356
10.1002/CNCR.23521
P407
P577
2008-06-01T00:00:00Z